Home
Browse
Search
Statistics
About
Usage
PMID: 22360349
Mandal D, Moitra K, Ghosh D, Xia D, Dey S
Evidence for modulatory sites at the lipid-protein interface of the human multidrug transporter P-glycoprotein.
Biochemistry. 2012 Apr 3;51(13):2852-66. Epub 2012 Mar 22.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
28
ABCB1 p.Gln990Ala
X
ABCB1 p.Gln990Ala 22360349:28:328
status:
NEW
view ABCB1 p.Gln990Ala details
ABCB1 p.Val988Ala
X
ABCB1 p.Val988Ala 22360349:28:320
status:
NEW
view ABCB1 p.Val988Ala details
ABCB1 p.Met986Ala
X
ABCB1 p.Met986Ala 22360349:28:312
status:
NEW
view ABCB1 p.Met986Ala details
ABCB1 p.Val991Ala
X
ABCB1 p.Val991Ala 22360349:28:340
status:
NEW
view ABCB1 p.Val991Ala details
ABCB1 p.Phe983Ala
X
ABCB1 p.Phe983Ala 22360349:28:304
status:
NEW
view ABCB1 p.Phe983Ala details
ABCB1 p.Thr945Ala
X
ABCB1 p.Thr945Ala 22360349:28:288
status:
NEW
view ABCB1 p.Thr945Ala details
ABCB1 p.Met948Ala
X
ABCB1 p.Met948Ala 22360349:28:296
status:
NEW
view ABCB1 p.Met948Ala details
ABCB1 p.Ile765Ala
X
ABCB1 p.Ile765Ala 22360349:28:216
status:
NEW
view ABCB1 p.Ile765Ala details
ABCB1 p.Ile764Ala
X
ABCB1 p.Ile764Ala 22360349:28:208
status:
NEW
view ABCB1 p.Ile764Ala details
ABCB1 p.Ala871Phe
X
ABCB1 p.Ala871Phe 22360349:28:280
status:
NEW
view ABCB1 p.Ala871Phe details
ABCB1 p.Leu772Ala
X
ABCB1 p.Leu772Ala 22360349:28:240
status:
NEW
view ABCB1 p.Leu772Ala details
ABCB1 p.Gly723Ala
X
ABCB1 p.Gly723Ala 22360349:28:200
status:
NEW
view ABCB1 p.Gly723Ala details
ABCB1 p.Ile840Ala
X
ABCB1 p.Ile840Ala 22360349:28:256
status:
NEW
view ABCB1 p.Ile840Ala details
ABCB1 p.Ile864Ala
X
ABCB1 p.Ile864Ala 22360349:28:264
status:
NEW
view ABCB1 p.Ile864Ala details
ABCB1 p.Val715Ala
X
ABCB1 p.Val715Ala 22360349:28:176
status:
NEW
view ABCB1 p.Val715Ala details
ABCB1 p.Ile768Ala
X
ABCB1 p.Ile768Ala 22360349:28:224
status:
NEW
view ABCB1 p.Ile768Ala details
ABCB1 p.Phe716Ala
X
ABCB1 p.Phe716Ala 22360349:28:184
status:
NEW
view ABCB1 p.Phe716Ala details
ABCB1 p.Ile719Ala
X
ABCB1 p.Ile719Ala 22360349:28:192
status:
NEW
view ABCB1 p.Ile719Ala details
ABCB1 p.Ile867Ala
X
ABCB1 p.Ile867Ala 22360349:28:272
status:
NEW
view ABCB1 p.Ile867Ala details
ABCB1 p.Phe770Ala
X
ABCB1 p.Phe770Ala 22360349:28:232
status:
NEW
view ABCB1 p.Phe770Ala details
ABCB1 p.Thr837Ala
X
ABCB1 p.Thr837Ala 22360349:28:248
status:
NEW
view ABCB1 p.Thr837Ala details
The desired nucleotide replacements were confirmed by Big-Dye version 3.1 (BD Sciences) nucleotide sequencing of the MDR1 open reading frame in recombinant plasmids pKM2-MDR1-
V715A
, -
F716A
, -
I719A
, -
G723A
, -
I764A
, -
I765A
, -
I768A
, -
F770A
, -
L772A
, -
T837A
, -
I840A
, -
I864A
, -
I867A
, -
A871F
, -
T945A
, -
M948A
, -
F983A
, -
M986A
, -
V988A
, -
Q990A
, and -
V991A
.
Login to comment
99
ABCB1 p.Ile765Ala
X
ABCB1 p.Ile765Ala 22360349:99:124
status:
NEW
view ABCB1 p.Ile765Ala details
ABCB1 p.Ile764Ala
X
ABCB1 p.Ile764Ala 22360349:99:135
status:
NEW
view ABCB1 p.Ile764Ala details
ABCB1 p.Leu772Ala
X
ABCB1 p.Leu772Ala 22360349:99:103
status:
NEW
view ABCB1 p.Leu772Ala details
ABCB1 p.Gly723Ala
X
ABCB1 p.Gly723Ala 22360349:99:63
status:
NEW
view ABCB1 p.Gly723Ala details
ABCB1 p.Val715Ala
X
ABCB1 p.Val715Ala 22360349:99:88
status:
NEW
view ABCB1 p.Val715Ala details
ABCB1 p.Ile768Ala
X
ABCB1 p.Ile768Ala 22360349:99:117
status:
NEW
view ABCB1 p.Ile768Ala details
ABCB1 p.Phe716Ala
X
ABCB1 p.Phe716Ala 22360349:99:77
status:
NEW
view ABCB1 p.Phe716Ala details
ABCB1 p.Ile719Ala
X
ABCB1 p.Ile719Ala 22360349:99:70
status:
NEW
view ABCB1 p.Ile719Ala details
ABCB1 p.Phe770Ala
X
ABCB1 p.Phe770Ala 22360349:99:110
status:
NEW
view ABCB1 p.Phe770Ala details
As one can see in Figure 2A, none of the substitutions in TM7 (
G723A
,
I719A
,
F716A
, and
V715A
) or TM8 (
L772A
,
F770A
,
I768A
,
I765A
, and
I764A
) was critical for stimulation of [125 I]IAAP binding by cis-(Z)-flupentixol.
Login to comment
102
ABCB1 p.Gln990Ala
X
ABCB1 p.Gln990Ala 22360349:102:116
status:
NEW
view ABCB1 p.Gln990Ala details
ABCB1 p.Val988Ala
X
ABCB1 p.Val988Ala 22360349:102:98
status:
NEW
view ABCB1 p.Val988Ala details
ABCB1 p.Met986Ala
X
ABCB1 p.Met986Ala 22360349:102:105
status:
NEW
view ABCB1 p.Met986Ala details
ABCB1 p.Phe983Ala
X
ABCB1 p.Phe983Ala 22360349:102:91
status:
NEW
view ABCB1 p.Phe983Ala details
ABCB1 p.Met948Ala
X
ABCB1 p.Met948Ala 22360349:102:84
status:
NEW
view ABCB1 p.Met948Ala details
A comparable level of basal binding of [125 I]IAAP to wild-type Pgp and Pgp mutants
M948A
,
F983A
,
V988A
,
M986A
, and
Q990A
(Figure 2B) rules out the possibility that the reduced level of stimulation in the mutants is due to loss of [125 I]IAAP binding and not stimulation per se. To investigate whether M948, Q990, F983, M986, and V988 are part of a general module involved in the regulation of substrate binding or are molecular components specific to cis- (Z)-flupentixol, we studied the effect of a structurally unrelated Pgp modulator, cyclosporin A, on binding of [125 I]IAAP to all 21 mutants.
Login to comment
110
ABCB1 p.Gln990Ala
X
ABCB1 p.Gln990Ala 22360349:110:1575
status:
NEW
view ABCB1 p.Gln990Ala details
ABCB1 p.Val988Ala
X
ABCB1 p.Val988Ala 22360349:110:1506
status:
NEW
view ABCB1 p.Val988Ala details
ABCB1 p.Met986Ala
X
ABCB1 p.Met986Ala 22360349:110:1438
status:
NEW
view ABCB1 p.Met986Ala details
ABCB1 p.Val991Ala
X
ABCB1 p.Val991Ala 22360349:110:1646
status:
NEW
view ABCB1 p.Val991Ala details
ABCB1 p.Phe983Ala
X
ABCB1 p.Phe983Ala 22360349:110:1367
status:
NEW
view ABCB1 p.Phe983Ala details
ABCB1 p.Thr945Ala
X
ABCB1 p.Thr945Ala 22360349:110:1250
status:
NEW
view ABCB1 p.Thr945Ala details
ABCB1 p.Met948Ala
X
ABCB1 p.Met948Ala 22360349:110:1319
status:
NEW
view ABCB1 p.Met948Ala details
ABCB1 p.Ile765Ala
X
ABCB1 p.Ile765Ala 22360349:110:715
status:
NEW
view ABCB1 p.Ile765Ala details
ABCB1 p.Ile764Ala
X
ABCB1 p.Ile764Ala 22360349:110:649
status:
NEW
view ABCB1 p.Ile764Ala details
ABCB1 p.Ala871Phe
X
ABCB1 p.Ala871Phe 22360349:110:1226
status:
NEW
view ABCB1 p.Ala871Phe details
ABCB1 p.Leu772Ala
X
ABCB1 p.Leu772Ala 22360349:110:900
status:
NEW
view ABCB1 p.Leu772Ala details
ABCB1 p.Gly723Ala
X
ABCB1 p.Gly723Ala 22360349:110:579
status:
NEW
view ABCB1 p.Gly723Ala details
ABCB1 p.Ile840Ala
X
ABCB1 p.Ile840Ala 22360349:110:1026
status:
NEW
view ABCB1 p.Ile840Ala details
ABCB1 p.Ile864Ala
X
ABCB1 p.Ile864Ala 22360349:110:1094
status:
NEW
view ABCB1 p.Ile864Ala details
ABCB1 p.Val715Ala
X
ABCB1 p.Val715Ala 22360349:110:396
status:
NEW
view ABCB1 p.Val715Ala details
ABCB1 p.Ile768Ala
X
ABCB1 p.Ile768Ala 22360349:110:763
status:
NEW
view ABCB1 p.Ile768Ala details
ABCB1 p.Ile719Ala
X
ABCB1 p.Ile719Ala 22360349:110:510
status:
NEW
view ABCB1 p.Ile719Ala details
ABCB1 p.Ile867Ala
X
ABCB1 p.Ile867Ala 22360349:110:1154
status:
NEW
view ABCB1 p.Ile867Ala details
ABCB1 p.Phe770Ala
X
ABCB1 p.Phe770Ala 22360349:110:831
status:
NEW
view ABCB1 p.Phe770Ala details
ABCB1 p.Thr837Ala
X
ABCB1 p.Thr837Ala 22360349:110:968
status:
NEW
view ABCB1 p.Thr837Ala details
Stimulation of ATP Hydrolysis by cis-(Z)-Flupentixol and Verapamil cis-(Z)-flupentixol-mediated stimulation verapamil-mediated stimulation maximal stimulation (x-fold basal) concentration for half-maximal stimulation (μM) remark maximal stimulation (x-fold basal) concentration for half-maximal stimulation (μM) remark WT 7.3 ± 0.4 6.8 ± 1.5 5.6 ± 0.19 6.6 ± 1.04
V715A
6.2 ± 0.2 5.0 ± 0.9 6.4 ± 0.37 16.3 ± 3.3 V716A 5.1 ± 0.2 4.7 ± 1.1 NDb NDb a
I719A
4.6 ± 0.08 4.7 ± 0.4 5.8 ± 0.26 6.5 ± 1.31
G723A
5.3 ± 0.3 10.93 ± 2.7 5.4 ± 0.1 11.6 ± 0.88
I764A
4.5 ± 0.4 4.1 ± 2 3.2 ± 0.26 27.9 ± 8.4
I765A
4.96 ± 0.2 2.3 ± 0.47 NDb NDb a
I768A
4.8 ± 0.2 1.2 ± 0.43 4.8 ± 0.19 8.5 ± 1.4
F770A
6.6 ± 0.6 10.9 ± 3.9 8.6 ± 0.59 13.2 ± 3.2
L772A
3.6 ± 0.2 2.96 ± 0.9 3.2 ± 0.11 9.5 ± 1.6
T837A
1.1 ± 0.06 NDb a 2.6 ± 0.1 3.1 ± 0.9
I840A
4.0 ± 0.3 25.6 ± 6.5 6.9 ± 0.2 13.5 ± 0.5
I864A
0.6 ± 0.05 NDb a 4.1 ± 0.25 0.9 ± 1.04
I867A
10.2 ± 1.3 72.3 ± 18.5 10.2 ± 0.52 30.7 ± 3.1
A871F
NDb NDb NDb NDb a
T945A
5.0 ± 0.3 13.7 ± 3.1 6.4 ± 0.15 6.9 ± 0.71
M948A
NDb NDb a 6.8 ± 1.5 44.4 ± 12.4
F983A
4.95 ± 0.36 19.59 ± 5.0 6.1 ± 0.38 6.6 ± 1.8
M986A
3.8 ± 0.3 2.6 ± 1.5 7.7 ± 0.76 30.0 ± 8.6
V988A
3.0 ± 0.2 21.4 ± 7.6 6.5 ± 0.31 16.9 ± 2.9
Q990A
1.8 ± 0.4 18.9 ± 2.6 a 7.7 ± 0.58 12.9 ± 3.7
V991A
3.9 ± 0.2 21.1 ± 5.0 5.9 ± 0.59 21.9 ± 7.2 a Mutants with <2-fold maximal stimulation (<25% of the wild-type level).
Login to comment
113
ABCB1 p.Val988Ala
X
ABCB1 p.Val988Ala 22360349:113:73
status:
NEW
view ABCB1 p.Val988Ala details
ABCB1 p.Ala871Phe
X
ABCB1 p.Ala871Phe 22360349:113:62
status:
NEW
view ABCB1 p.Ala871Phe details
ABCB1 p.Ile867Ala
X
ABCB1 p.Ile867Ala 22360349:113:55
status:
NEW
view ABCB1 p.Ile867Ala details
Although a moderate effect was observed in Pgp mutants
I867A
,
A871F
, and
V988A
, none of the replacements proved to be absolutely critical for inhibition by cyclosporin A (Figure 3).
Login to comment
135
ABCB1 p.Ile764Ala
X
ABCB1 p.Ile764Ala 22360349:135:74
status:
NEW
view ABCB1 p.Ile764Ala details
ABCB1 p.Leu772Ala
X
ABCB1 p.Leu772Ala 22360349:135:64
status:
NEW
view ABCB1 p.Leu772Ala details
Although a moderate loss of stimulation was observed in mutants
L772A
and
I764A
, a >2-fold residual activity in each case suggested that neither of the two residues was indispensable.
Login to comment
137
ABCB1 p.Ala871Phe
X
ABCB1 p.Ala871Phe 22360349:137:48
status:
NEW
view ABCB1 p.Ala871Phe details
This, however, was with the exception of mutant
A871F
, which replaced a naturally occurring alanine with a phenylalanine.
Login to comment
138
ABCB1 p.Ala871Phe
X
ABCB1 p.Ala871Phe 22360349:138:35
status:
NEW
view ABCB1 p.Ala871Phe details
The more general effect evident in
A871F
most likely represented a local structural perturbation caused by replacement of the methyl side chain of alanine with a bulkier benzyl functional group of phenylalanine.
Login to comment
200
ABCB1 p.Gln990Ala
X
ABCB1 p.Gln990Ala 22360349:200:201
status:
NEW
view ABCB1 p.Gln990Ala details
ABCB1 p.Ile864Ala
X
ABCB1 p.Ile864Ala 22360349:200:191
status:
NEW
view ABCB1 p.Ile864Ala details
As one can see in the top panels (middle and right) of Figure 8, the negative synergistic effect of cis-(Z)-flupentixol on verapamil-stimulated ATP hydrolysis was considerably compromised in
I864A
and
Q990A
, Pgp mutants defective with respect to ATP-site stimulation by cis-(Z)-flupentixol.
Login to comment
201
ABCB1 p.Ile765Ala
X
ABCB1 p.Ile765Ala 22360349:201:162
status:
NEW
view ABCB1 p.Ile765Ala details
Reciprocally, the inhibitory effect of verapamil on cis-(Z)-flupentixol-mediated stimulation of the ATP site was obliterated in the verapamil-specific Pgp mutant
I765A
(Figure 8, bottom right).
Login to comment
205
ABCB1 p.Gln990Ala
X
ABCB1 p.Gln990Ala 22360349:205:55
status:
NEW
view ABCB1 p.Gln990Ala details
ABCB1 p.Ile765Ala
X
ABCB1 p.Ile765Ala 22360349:205:66
status:
NEW
view ABCB1 p.Ile765Ala details
ABCB1 p.Ile864Ala
X
ABCB1 p.Ile864Ala 22360349:205:48
status:
NEW
view ABCB1 p.Ile864Ala details
ATP hydrolysis by the wild type and Pgp mutants
I864A
,
Q990A
, and
I765A
, in isolated membrane vesicles, was conducted either after preincubation with 50 μM verapamil (top) or with 50 μM cis-(Z)-flupentixol (bottom) followed by incubation with increasing concentrations of cis-(Z)-flupentixol (top) or verapamil (bottom), using the vanadate-sensitive phosphate release assay.
Login to comment
224
ABCB1 p.Val988Ala
X
ABCB1 p.Val988Ala 22360349:224:32
status:
NEW
view ABCB1 p.Val988Ala details
ABCB1 p.Met986Ala
X
ABCB1 p.Met986Ala 22360349:224:21
status:
NEW
view ABCB1 p.Met986Ala details
ABCB1 p.Phe983Ala
X
ABCB1 p.Phe983Ala 22360349:224:14
status:
NEW
view ABCB1 p.Phe983Ala details
Substitutions
F983A
,
M986A
, and
V988A
completely abrogate stimulation of substrate binding (Figure 2) with only modest effects on ATP-site stimulation (Figure 4), which indicates that the two modulatory events are not tightly coupled to each other.
Login to comment
225
ABCB1 p.Ile864Ala
X
ABCB1 p.Ile864Ala 22360349:225:56
status:
NEW
view ABCB1 p.Ile864Ala details
ABCB1 p.Thr837Ala
X
ABCB1 p.Thr837Ala 22360349:225:46
status:
NEW
view ABCB1 p.Thr837Ala details
Similarly, a reciprocal effect was evident in
T837A
and
I864A
, where a 34-fold stimulation of substrate binding was retained (Figure 2) even though ATP-site stimulation was almost abrogated (Figure 4).
Login to comment